p-Butyl Ibuprofen Sodium Salt

• CAT Number: R051760
• CAS Number: 3585-49-7
• Molecular Formula: C13H18O2
• Molecular Weight: 206.29
• Purity: ≥95%
• Synonyms: 4-Butyl-α-methylbenzeneacetic Acid Sodium Salt; p-Butylhydratropic Acid Sodium Salt; 2-(4-n-Butylphenyl)propionic Acid Sodium Salt; 2-(p-Butylphenyl)propionic Acid Sodium Salt; 4-Butyl-α-methylbenzeneacetic Acid Sodium Salt
• Storage: -20°C
• IUPAC Name: 2-(4-butylphenyl)propanoic acid
• InChI: InChI=1S/C13H18O2/c1-3-4-5-11-6-8-12(9-7-11)10(2)13(14)15/h6-10H,3-5H2,1-2H3,(H,14,15)
• InChIKey: FEFPDZIYEWFQFK-UHFFFAOYSA-N
• SMILES: CCCCC1=CC=C(C=C1)C(C)C(=O)O

p-Butyl ibuprofen sodium salt (Cat No.: R051760) is a modified nonsteroidal anti-inflammatory drug (NSAID) derived from ibuprofen, where a butyl group is introduced at the para position of the aromatic ring and the carboxylic acid is converted to its sodium salt form. This structural modification enhances its solubility in aqueous solutions and may influence pharmacokinetics or tissue distribution. Like ibuprofen, it exhibits analgesic, antipyretic, and anti-inflammatory properties. It is used in pharmaceutical research to explore structure–activity relationships and improve drug delivery and bioavailability.